Bulletin
Investor Alert

New York Markets Close in:

Company Close Updates Archives | Email alerts

Aug. 10, 2020, 4:25 p.m. EDT

Johnson & Johnson stock underperforms Monday when compared to competitors

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Johnson & Johnson JNJ slipped 0.38% to $148.03 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.27% to 3,360.47 and the Dow Jones Industrial Average DJIA rising 1.30% to 27,791.44. Johnson & Johnson closed $8.97 short of its 52-week high ($157.00), which the company achieved on April 23rd.

The stock underperformed when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. RHHVF rose 0.78% to $344.71, Merck & Co. Inc. MRK fell 0.14% to $80.91, and Pfizer Inc. PFE fell 0.16% to $38.39. Trading volume (4.0 M) remained 2.7 million below its 50-day average volume of 6.7 M.

Click here to let us know what you think about this content.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.